Xebra Brands Faces Cease Trade Order Amid Filing Delays

Xebra Brands Ltd., a cannabis company based in Vancouver, announced it will likely receive a cease trade order (CTO) from the British Columbia Securities Commission due to its inability to file required financial statements by the set deadline. The missed filings include the company’s annual and interim financial statements for the year ending February 28, 2025. This will result in a suspension of trading on the Canadian Securities Exchange.

The anticipated CTO follows a previously issued management cease trade order, as Xebra faced liquidity issues and management changes. A terminated loan agreement, meant to facilitate the filings, adds to the challenges. However, the company has identified potential new funding sources and plans to update investors on future capital procurement.

The company's shares have been moved from the OTCQB Market to the OTC Pink Open Market, reflecting the trading restrictions imposed by the CTO. The CTO, once issued, will prohibit trade across Canada until compliance is restored.